These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 17436021)

  • 1. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidase activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Linardi A; Panunto PC; Ferro ES; Hyslop S
    Biochem Pharmacol; 2004 Jul; 68(2):205-14. PubMed ID: 15193992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
    J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D; Cederbaum A
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X; Matavelli LC; Ono H; Frohlich ED
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat.
    Yang Y; Macdonald GJ; Duggan KA
    Clin Sci (Lond); 2001 Mar; 100(3):319-26. PubMed ID: 11222119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
    Bernátová I; Pechánová O; Simko F
    Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitor and AT1 antagonist stimulate duodenal HCO3- secretion mediated by a common pathway - involvement of PG, NO and bradykinin.
    Aihara E; Kagawa S; Hayashi M; Takeuchi K
    J Physiol Pharmacol; 2005 Sep; 56(3):391-406. PubMed ID: 16204762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.